About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72722 record(s)
Req # A-2020-001610
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-114416-734.Organization: Health Canada
April 2024
Req # A-2021-000028
Adverse Drug Reactions (ADRs). Report numbers: 000928579, E2B_01441318, E2B_03408201, E2B_03408205, E2B_03408767, E2B_03408772, E2B_03409939, E2B_03419846, E2B_03421929, E2B_03422163, E2B_03440717, E2B_03442217, E2B_03443245, E2B_03451400,…Organization: Health Canada
April 2024
Req # A-2021-000404
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105904-139, Proposed Critical Drug Reserve Procurement Action.Organization: Health Canada
April 2024
Req # A-2021-000808
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03467449, E2B_03468879, E2B_03512908, E2B_03487062, 000929339, E2B_03484816, E2B_03507339, E2B_03378451, E2B_03511470, E2B_03464271, E2B_03512885, E2B_03443839,…Organization: Health Canada
April 2024
Req # A-2021-001496
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: E2B_04403239, E2B_04478607, E2B_04410041, E2B_04374569, E2B_04396043, E2B_04392143, E2B_04370904, E2B_04371940, E2B_04411181, E2B_04411529, E2B_04411619, E2B_04475791,…Organization: Health Canada
April 2024
Req # A-2021-001595
Adverse Drug Reactions (ADRs). Report numbers: E2B_04517612, E2B_04533637, 000970662, E2B_04580127, 000962489, 000966607, 000969985, E2B_04607680, E2B_02153005, E2B_03530953, E2B_04582750, E2B_04502921, E2B_04528744, E2B_04513381, E2B_04512231,…Organization: Health Canada
April 2024
Req # A-2021-001982
Adverse Drug Reactions (ADRs). Report numbers: E2B_04809512, E2B_04814716, E2B_04788436, E2B_04816188, E2B_04797467, E2B_04778253, E2B_04821689, E2B_04821722, E2B_04782548, 000973761, E2B_04752615, E2B_04816220, 000970576, E2B_04247184, E2B_04797500…Organization: Health Canada
April 2024
Req # A-2021-002023
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-108457-361.Organization: Health Canada
April 2024
Req # A-2022-000778
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108685-224.Organization: Health Canada
April 2024
Req # A-2022-001613
Adverse Drug Reactions (ADRs). Report numbers: E2B_02421473, E2B_02432885, 000972235, E2B_04582728, E2B_02476812, 000729247, E2B_02540141, 000729578, E2B_02568224, E2B_02640414.Organization: Health Canada
April 2024